By ALAN WINKELSTEIN, ROBERT S. SPARKES AND CHARLES G. CRADDOCK I HE MYELOPROLIFERATIVE syndrome comprises a spectrum of neoplastic disorders with merging clinical, pathologic and hematologic features. These disorders result from the abnormal proliferation, either in the bone marrow or potential marrow sites, of one or more of the marrow elements. Morphologically, the syndrome can be subdivided ...
